Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions. Check out our latest thought leadership pieces below.

Two hands holding a comment bubble with a heart, surrounded by comment bubbles

Debunking the 5 Biggest Myths About Community-Based Advertising

March 2, 2026

This article explores the 2026 shift in pharma marketing, debunking five common misconceptions to position online health communities as essential strategic powerhouses.

A person reaches through a cloud of random numbers and symbols into a portal revealing a health care provider reaching back at them.

Bridging the Gap: Tailoring Research for Hard-to-Engage Patient Populations

February 24, 2026

Explore strategic ways to engage hard-to-reach patient populations by prioritizing humility, empathetic design, and flexible research methodologies over standard demographic data

Case Study: Beyond the Target List

February 20, 2026

Learn how data-driven HCP audience expansion reignited a mature pharma brand.

Influencer Certification Playbook? We Wrote It Years Ago.

February 17, 2026

Discover how a decade of rigorous training, regulatory mastery, and certified patient expertise transforms influencer marketing into a compliant gold standard for pharma brands.

IBS Patient-Reported Survey Data 2020

October 19, 2020

Merely 9% of people living with IBS were currently taking a prescription IBS medication, according to new Health Union patient-reported survey data.

Alzheimer’s Disease Patient-Reported Survey Data | 2020

October 6, 2020

Only 11% of people living with Alzheimer’s disease feel controlled on their current treatment plan, according to Health Union patient-reported survey data.

COPD Patient-Reported Survey Data | 2020

September 23, 2020

44% of people living with COPD who experience pain consider themselves as having chronic pain, according to new Health Union survey data.

Multiple Sclerosis Patient-Reported Survey Data | 2020

September 10, 2020

71% of people living with multiple sclerosis currently use a DMT but many live with pain and emotional grief, according to new Health Union survey data.

Healthcare Industry Thought Leadership

Contact